Research: Pfizer Inc.

Articles found below have been submitted through various PR and news sources and don’t necessary reflect the views of SalesTrax or its employees.

Scrip World Pharmaceutical News

2011-12-20 21:47
Pfizer files petition with Supreme Court to review Norvasc case
Pfizer asked the US Supreme Court on May 31st to delay the effect of the Federal Circuit's rulings against the company relating to its patents on Norvasc. It argues that the Circuit Court failed to apply the Supreme Court's unanimous ruling a few weeks ago in KSR v Teleflex, "which altered the Federal Circuit's established framework for determining obviousness".

PR Newswire

2009-09-24 16:00
Michigan Life Science and Innovation Center Opens in Former Pfizer Facility

2009-09-21 20:00
Boehringer Ingelheim Animal Health Enters into Agreement to Acquire Certain Assets of Fort Dodge Animal Health from Pfizer

2009-09-14 08:00
By 2018, GlaxoSmithKline's Votrient Will Garner Sales of $640 Million and Will Overtake Pfizer's Sutent as the Renal Cell Carcinoma Market Leader

2009-09-09 16:00
AUDIO from Medialink and Pfizer: September is Pain Awareness Month

2009-09-02 16:00
Comments on Behalf of Whistleblower Glen DeMott on False Claims Act Settlement Reached with Pfizer

2009-09-02 12:00
Bextra Whistleblower Case Started Investigation of Pfizer

2009-09-02 12:00
Pfizer Pays a Record Amount to Settle Federal and State Fraud Investigations Into Illegal Off-Label Marketing Practices

2009-09-02 12:00
Sheller, P.C. Law Firm Instrumental in Pfizer's $2.3 Billion Settlement Today in Largest Pharmaceutical Whistleblower Case in History

2009-08-28 16:00
AUDIO from Medialink, Boehringer Ingelheim Pharmaceuticals, Inc. & Pfizer Inc.: Coping with Chronic Obstructive Pulmonary Disease (COPD)

2009-08-20 08:00
Secure eHealth License Holder Private Access, Inc. Announces Commercial Beta Release of Privacy-Enhanced Search Technology, Including Collaboration with Pfizer, Inc.

2009-07-28 12:00
Big Put Volume in Pfizer, Inc. (PFE) and Merck & Co., Inc. (MRK) - Reports

2009-07-14 16:00
Burrill Merchant Banking Advises Pfizer Inc. on Dermatology Portfolio Divestment

2009-06-26 08:00 Researches Market Movers: Kimberly-Clark, PetroQuest, Pfizer, Dress Barn and McCormick

Pharmaceutical Business Review

2009-09-22 12:04
Icagen Extends Collaboration With Pfizer
Icagen and Pfizer have extended partnership to identify compounds that target three ion channels

2009-09-22 12:04
Boehringer Ingelheim Enters Into Agreement With Pfizer To Acquire Assets Of Fort Dodge Animal Health
Acquisition will strengthen Boehringer Ingelheim?s position as a vaccine supplier

2009-08-29 04:03
Abbott Enters Into Agreement With Pfizer
To develop a molecular diagnostic test intended to screen NSCLC tumors for the presence of gene rearrangements

2009-08-27 16:03
Pfizer Signs Co-promotion Agreement For Caduet Combination Tablets With Astellas
Pfizer, responsible for manufacturing and sales of the tablets

2009-08-26 16:03
Pfizer Commences New Biotech Facility In Sweden
Company invested $214.8m in the plant at Strangnas

2009-08-20 12:03
Pfizer Forms Collaboration With Private Access
The new online community aimed at increasing clinical trial awareness and participation

2009-07-31 08:03
Pfizer, Medivation Initiate Phase 3 Trial Of Dimebon
Entitled to a seven-year period of marketing exclusivity in the US

2009-07-30 04:03
Pfizer Signs Research Partnership With SIBS
To support fundamental research in China

2009-07-22 12:04
Pfizer Reports Second-Quarter 2009 Results
Reported net income of $2.3 billion, a decline of 19%

2009-07-22 08:02
Pfizer Presents 96-Week MERIT ES Results
Data showed favorable tolerability of Celsentri/Selzentry

2009-07-21 12:05
European Commission Approves Pfizer's Pending Acquisition Of Wyeth
Also, China?s Ministry of Commerce has extended review of Pfizer?s regulatory submission beyond the initial thirty-day period

2009-07-16 04:03
Pfizer Presents Phase 1 Result For Alzheimer?s Study
Compound was well-tolerated in patients, with no clinical or imaging evidence of vasogenic edema

2009-07-10 12:04
Pfizer To Appeal Canadian Federal Court Decision On Norvasc Patent
Patent covering amlodipine besylate was declared invalid

2009-07-02 16:04
Graceway Signs Acquisition, License Agreement With Pfizer
Graceway to acquire worldwide commercial rights for three investigational dermatological molecules from Pfizer

2009-07-01 12:04
Pfizer Discontinues Phase-III Trial Of Sutent
Sutent to treat patients with metastatic colorectal cancer

2009-06-26 04:04
Pfizer Reports Positive Results For Phase-III Sutent Trial
Demonstrated median progression-free survival of 11.1 months in patients with advanced pancreatic islet cell tumors

2009-06-19 04:03
SEC Declares Pfizer? Registration Statement Effective For Acquisition Of Wyeth
Transaction expected to close during the fourth quarter of 2009

2009-06-04 04:03
Pfizer Launches New Treatment For Overactive Bladder
Toviaz, a once daily prescription drug, is available in doses of 4mg and 8mg

2009-06-03 12:03
Pfizer Discontinues Sunitinib Plus Paclitaxel Trial
Pfizer continues to evaluate sunitinib through two other Phase-III clinical trials

2009-06-02 04:03
Pfizer, Celldex Provides Update On Brain Cancer Studies
Pfizer and Celldex Therapeutics has announced the updated data from two clinical trials of CDX-110 in newly-diagnosed glioblastoma multiforme (GBM) at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO). CDX-110, an investigational immunotherapeutic vaccine that targets the tumor-specific molecule, epidermal growth factor receptor variant III (EGFRvIII).

2009-06-01 04:03
Pfizer Upbeat About Study Results For NSCLC Treatment
Pfizer has reported positive results from studies evaluating the anti-insulin growth factor type 1 receptor (IGF-1R) antibody, figitumumab (CP-751,871), in patients with non-small cell lung cancer (NSCLC). Figitumumab, an investigational fully human monoclonal antibody, is a highly specific inhibitor of the insulin growth factor-1 receptor (IGF-1R) pathway.

2009-06-01 04:03
Pfizer' Reveals Results For Four Lung Cancer Trials
Pfizer has announced positive results from four studies highlighting clinical data with targeted treatment approaches in patients with non-small cell lung cancer. The ongoing trial is targeted at the company's c-Met/ALK Inhibitor, Pan-HER Inhibitor, Axitinib and Figitumumab. The results for the trials were presented at ASCO, Orlando.

2010-10-28 20:00
Should Pfizer Split Itself Up?
Shareholders would be better off if some parts of the company were spun off.

2010-08-17 20:00
Growing Pfizer
Lessons and challenges from growing a business dependent on medical innovation.

2009-11-13 08:00
Layoffs Sting Big Pharma
Merger-related cuts at Merck and Pfizer show how the mighty drug industry has fallen.

2009-10-09 16:00
Pfizer Suspends Lung Cancer Study
The news is another setback for Pfizer as it makes a big push into cancer drugs.